Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04860856 · ClinicalTrials.gov registry record · Phase 4
Efficacy of Hematoma Block on Postoperative Pain After Femoral Intramedullary Rodding: A Randomized Trial
A Phase 4 study of Femur Fracture, sponsored by University of Cincinnati.
- Completed
- Registry status
- Phase 4
- Development phase
- 88
- Enrollment target
- 1
- Study location
NCT04860856: Completed Phase 4 study of Femur Fracture, sponsored by University of Cincinnati.
NCT04860856 is a Phase 4 study of Femur Fracture that has completed, run by University of Cincinnati. The registered enrollment target is 88 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04860856, a Phase 4 study of Femur Fracture, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 88 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the efficacy of an intra-operative, post-fixation fracture hematoma block compared to saline control on postoperative pain control in patients with acute femoral shaft fractures. Our primary outcome measure is visual analog scale (VAS) pain scores which are recorded at regular intervals.
Primary Outcome
Postoperative pain will be assessed using a visual analog scale
Conditions Studied
Interventions
- DRUG Normal Saline
- DRUG 0.5% ropivacaine
Study Locations (1)
Ohio
- University of Cincinnati College of Medicine - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2019-08-17 |
| Est. Completion | 2023-02-07 |
| Phase | Phase 4 |
What the finished NCT04860856 record still lists
NCT04860856 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Femur Fracture appearing as the primary indexed condition, and to 2 interventions - of which Normal Saline is the first listed.
NCT04860856 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04860856 about?
NCT04860856 is a clinical study titled "Efficacy of Hematoma Block on Postoperative Pain After Femoral Intramedullary Rodding: A Randomized Trial". The purpose of this study is to evaluate the efficacy of an intra-operative, post-fixation fracture hematoma block compared to saline control on postoperative pain control in patients with acute femoral shaft fractures. Our primary outcome measure is visual analog scale (VAS) pain scores which are r...
What is the current status of trial NCT04860856?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 88 participants. The study started on 2019-08-17. Estimated completion is 2023-02-07.
What conditions does trial NCT04860856 study?
This clinical trial studies the following conditions: Femur Fracture.
What interventions are being tested in trial NCT04860856?
The interventions under investigation include: Normal Saline (DRUG), 0.5% ropivacaine (DRUG).
Who is sponsoring clinical trial NCT04860856?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04860856 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Femur Fracture
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04860856's enrollment target sits among peer trials
88 916th of 2000 higher than 1,078 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI